eastman kodak said has acquir pct equiti interest enzon inc pharmaceut compani special protein therapi kodak said secur worldwid market right for three enzon peg enzym use treatment oxygen toxic disord hyperuricemia and gout compani said acquir two mln enzon share for mln dlrs with loan enzon two mln dlrs and interest 000 dlrs credit against purchas price kodak said drug cover market right initi stage food and drug administr approv process said invest should necessari capit complet fda review process and market outlet for drug drug peg superoxid disdmutas and peg catalas for against oxygen toxic disord often fatal tissu damag associ with sever burn organ transplant heart attack and trauma and peg uricas for treatment gout and condit caus buildup high level uric acid bodi reuter 